Chart: Revenue Flow for Edwards Lifesciences. Q2 2026, values in USD. Revenue 41%, Gross Profit 32%, Operating Income 12%, Cost of Revenue 9%, Net Income 6%.
Balance Sheet
Chart: Balance Sheet for Edwards Lifesciences. Values in currency. In Q2 2026: Total Assets 13.867, Total Liabilities 3.142, Total Equity 10.618.
Q3 2016-Q2 2026
Cash Flow
Chart: Cash Flow for Edwards Lifesciences. Values in currency. In Q2 2026: Operating Cash Flow 0.652, Free Cash Flow 0.585, Capital Expenditures 0.067.
Q3 2016-Q2 2026
Revenue Breakdown
Chart: Revenue Breakdown for Edwards Lifesciences. Values in USD billions. In Q2 2026: Revenue 1.741, Gross Profit 1.35, Operating Income 0.519.